Cita APA (7a ed.)

L, Z., F, C., S, G., X, W., L, G., Y, L., . . . S, Y. (2020). Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press.

Cita Chicago Style (17a ed.)

L, Zhang, Chen F, Geng S, Wang X, Gu L, Lang Y, Li T, y Ye S. Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press, 2020.

Cita MLA (8a ed.)

L, Zhang, et al. Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press, 2020.